ImmunoPrecise Antibodies Ltd. (IPA)
IPA Stock Price Chart
Explore ImmunoPrecise Antibodies Ltd. interactive price chart. Choose custom timeframes to analyze IPA price movements and trends.
IPA Company Profile
Discover essential business fundamentals and corporate details for ImmunoPrecise Antibodies Ltd. (IPA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 Jan 2002
Employees
72.00
Website
https://www.ipatherapeutics.comCEO
Jennifer Lynne Bath
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.
IPA Financial Timeline
Browse a chronological timeline of ImmunoPrecise Antibodies Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Mar 2026
Upcoming earnings on 8 Dec 2025
Upcoming earnings on 15 Sept 2025
EPS estimate is -$0.04, while revenue estimate is $5.90M.
Earnings released on 29 Jul 2025
EPS came in at -$0.04 falling short of the estimated -$0.02 by -100.00%, while revenue for the quarter reached $5.06M , missing expectations by -20.99%.
Earnings released on 28 Mar 2025
EPS came in at -$0.06 matching the estimated -$0.06, while revenue for the quarter reached $4.17M , missing expectations by -47.14%.
Earnings released on 10 Dec 2024
EPS came in at -$0.09 matching the estimated -$0.09, while revenue for the quarter reached $4.40M , missing expectations by -36.87%.
Earnings released on 16 Sept 2024
EPS came in at -$0.11 falling short of the estimated -$0.09 by -22.22%, while revenue for the quarter reached $3.79M , missing expectations by -23.69%.
Earnings released on 29 Jul 2024
EPS came in at -$0.52 falling short of the estimated -$0.10 by -420.00%, while revenue for the quarter reached $4.72M , beating expectations by +0.10%.
Earnings released on 14 Mar 2024
EPS came in at -$0.08 falling short of the estimated -$0.07 by -7.54%, while revenue for the quarter reached $4.47M , missing expectations by -1.03%.
Earnings released on 31 Jan 2024
EPS came in at -$0.08 , while revenue for the quarter reached $4.63M .
Earnings released on 14 Sept 2023
EPS came in at -$0.11 surpassing the estimated -$0.17 by +35.29%, while revenue for the quarter reached $3.87M , missing expectations by -1.95%.
Earnings released on 4 Aug 2023
EPS came in at -$0.17 falling short of the estimated $0.12 by -241.67%, while revenue for the quarter reached $4.23M .
Earnings released on 10 Jul 2023
EPS came in at -$0.15 falling short of the estimated -$0.12 by -25.00%, while revenue for the quarter reached $4.13M , missing expectations by -3.63%.
Earnings released on 15 Dec 2022
EPS came in at -$0.23 falling short of the estimated -$0.14 by -64.29%, while revenue for the quarter reached $3.80M , beating expectations by +2.00%.
Earnings released on 14 Sept 2022
EPS came in at -$0.30 falling short of the estimated -$0.20 by -50.00%, while revenue for the quarter reached $3.65M , missing expectations by -11.74%.
Earnings released on 30 Apr 2022
EPS came in at -$0.17 , while revenue for the quarter reached $4.08M .
Earnings released on 16 Mar 2022
EPS came in at -$0.16 matching the estimated -$0.16, while revenue for the quarter reached $3.79M , missing expectations by -3.57%.
Earnings released on 13 Dec 2021
EPS came in at -$0.26 falling short of the estimated -$0.17 by -52.94%, while revenue for the quarter reached $3.82M , missing expectations by -6.90%.
Earnings released on 9 Sept 2021
EPS came in at -$0.13 , while revenue for the quarter reached $3.67M .
Earnings released on 28 Jul 2021
EPS came in at -$0.24 , while revenue for the quarter reached $3.96M .
Earnings released on 17 Mar 2021
EPS came in at -$0.08 surpassing the estimated -$0.14 by +42.86%, while revenue for the quarter reached $3.53M .
Earnings released on 21 Dec 2020
EPS came in at -$0.03 falling short of the estimated -$0.02 by -50.00%, while revenue for the quarter reached $3.58M .
Stock split effective on 23 Nov 2020
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
IPA Stock Performance
Access detailed IPA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.